Sulforaphane induces cell cycle arrest by protecting RB-E2F-1 complex in epithelial ovarian cancer cells

[1]  J. Chovancová,et al.  Administration of isothiocyanate (E-4IB) and cisplatin leads to altered signalling and lysosomal export in human ovarian carcinoma sensitive- and cisplatin-resistant cells. , 2009, Neoplasma.

[2]  R. Batchu,et al.  Ritonavir blocks AKT signaling, activates apoptosis and inhibits migration and invasion in ovarian cancer cells , 2009, Molecular Cancer.

[3]  Ajay P. Singh,et al.  Isothiocyanate NB7M causes selective cytotoxicity, pro-apoptotic signalling and cell-cycle regression in ovarian cancer cells , 2008, British Journal of Cancer.

[4]  D. Suh,et al.  Significance of E2F-1 overexpression in epithelial ovarian cancer , 2007, International Journal of Gynecologic Cancer.

[5]  S. Orsulic,et al.  Antiproliferative activity of sulforaphane in Akt-overexpressing ovarian cancer cells , 2007, Molecular Cancer Therapeutics.

[6]  C. Bose.  Comments regarding: Benzyl isothiocyanate (BITC) induces apoptosis in ovarian cancer cells in vitro Kalkunte S, Swamy N, Dizon DS, Brard L. J Exp Ther Oncol.5(4):287-300, 2006. , 2007, Journal of experimental therapeutics & oncology.

[7]  N. Concin,et al.  Expression of the E2F Family of Transcription Factors and Its Clinical Relevance in Ovarian Cancer , 2006, Annals of the New York Academy of Sciences.

[8]  P. Kvasnička,et al.  Sensitisation for cisplatin-induced apoptosis by isothiocyanate E-4IB leads to signalling pathways alterations , 2006, British Journal of Cancer.

[9]  N. Swamy,et al.  Phenethyl isothiocyanate (PEITC) inhibits growth of ovarian cancer cells by inducing apoptosis: role of caspase and MAPK activation. , 2006, Gynecologic oncology.

[10]  P. Steeg.  Tumor metastasis: mechanistic insights and clinical challenges , 2006, Nature Medicine.

[11]  R. Ozols,et al.  Challenges for chemotherapy in ovarian cancer. , 2006, Annals of oncology : official journal of the European Society for Medical Oncology.

[12]  E. Ho,et al.  Sulforaphane inhibits histone deacetylase activity in BPH-1, LnCaP and PC-3 prostate epithelial cells. , 2006, Carcinogenesis.

[13]  R. Dashwood,et al.  Chemoprotection by sulforaphane: keep one eye beyond Keap1. , 2006, Cancer letters.

[14]  N. Swamy,et al.  Benzyl isothiocyanate (BITC) induces apoptosis in ovarian cancer cells in vitro. , 2006, Journal of experimental therapeutics & oncology.

[15]  Shivendra V. Singh,et al.  Bax and Bak are required for apoptosis induction by sulforaphane, a cruciferous vegetable-derived cancer chemopreventive agent. , 2005, Cancer research.

[16]  A. Kong,et al.  Chemoprevention by isothiocyanates and their underlying molecular signaling mechanisms. , 2004, Mutation research.

[17]  J. Trimbos,et al.  Chemotherapy for early ovarian cancer , 2004, Current opinion in obstetrics & gynecology.

[18]  J. Pezzuto,et al.  Botanicals in Cancer Chemoprevention , 2004, Cancer and Metastasis Reviews.

[19]  I. Vergote,et al.  Treatment of patients with early epithelial ovarian cancer , 2003, Current opinion in oncology.

[20]  J. Fahey,et al.  Phytochemicals from cruciferous plants protect against cancer by modulating carcinogen metabolism. , 2001, The Journal of nutrition.

[21]  Taylor Murray,et al.  Cancer Statistics, 2001 , 2001, CA: a cancer journal for clinicians.

[22]  B. Gallie,et al.  Retinoblastoma: the disease, gene and protein provide critical leads to understand cancer. , 2000, Seminars in cancer biology.

[23]  C. Sherr.  The Pezcoller lecture: cancer cell cycles revisited. , 2000, Cancer research.

[24]  A. Koff,et al.  Cell-cycle inhibitors: three families united by a common cause. , 2000, Gene.

[25]  E. Partridge,et al.  Cyclophosphamide and cisplatin compared with paclitaxel and cisplatin in patients with stage III and stage IV ovarian cancer , 1996, The New England journal of medicine.

[26]  C Haanen,et al.  A novel assay for apoptosis. Flow cytometric detection of phosphatidylserine expression on early apoptotic cells using fluorescein labelled Annexin V. , 1995, Journal of immunological methods.

[27]  N. L. Thangue,et al.  DP and E2F proteins: components of a heterodimeric transcription factor implicated in cell cycle control , 1994 .

[28]  H C Hemker,et al.  Binding of vascular anticoagulant alpha (VAC alpha) to planar phospholipid bilayers. , 1990, The Journal of biological chemistry.